NCT03784703View on ClinicalTrials.gov

Type 2 Diabetic Patients Maintained on Statin Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 30, 2020

Study Completion Date

January 31, 2020

Conditions
Dyslipidemia Associated With Type II Diabetes Mellitus
Interventions
DRUG

Atorvastatin 40 Mg Oral Tablet

40 mg per day atorvastatin (ATROVA group, n= 80) for 6 months

DRUG

Rosuvastatin 10 Mg Oral Tablet

10 mg per day rosuvastatin (ROSUVA group, n= 80) for 6 months

Trial Locations (1)

31527

Tanta University Hospital, Tanta

All Listed Sponsors
collaborator

Tanta University

OTHER

lead

Damanhour University

OTHER

NCT03784703 - Type 2 Diabetic Patients Maintained on Statin Therapy | Biotech Hunter | Biotech Hunter